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The human growth hormone (hGH) has been expressed in prokaryotic expression system with low bioactivity previously. Then
the eﬀective B. mori baculovirus system was employed to express hGH identical to mature hGH successfully in larvae, but the
expression level was still limited. In this work, the hGH was expressed in B. mori pupae by baculovirus system. Quantiﬁcation of
recombinanthGHprotein(BmrhGH)showedthattheexpressionofBmrhGHreachedthelevelofapproximately890μg/mLpupae
supernatant solution, which was ﬁve times more than the level using larvae. Furthermore, Animals were gavaged with BmrhGH at
the dose of 4.5mg/rat.day, and the body weight gain (BWG) of treated group had a signiﬁcant diﬀerence (P<. 01) compared with
the control group. The other two parameters of liver weight and epiphyseal width were also found to be diﬀerent between the two
groups (P<. 05). The results suggested that BmrhGH might be used as a protein drug by oral administration.
1.Introduction
The human growth hormone (hGH) is a ∼22 kDa polypep-
tide synthesized and stored by somatotroph cells within the
anteriorpituitarygland.Itactseitherdirectlyorindirectlyon
varioustissuesandphysiologicalsystemssuchaslongitudinal
bone, skeletal muscle, liver, total body nitrogen balance,
a n ds oo n[ 1]. Expression of hGH polypeptide has been
performed in Escherichia coli [2]. Since the signal peptides of
proteins from eukaryotes are not recognized in prokaryotes,
fusion proteins such as maltose binding protein mal E[ 3]
or thioredoxin [4]h a v eb e e nu s e dt op r o d u c ea c t i v er h G H
protein. A major disadvantage of this approach is that the
fusion partner contributing the majority of the total mass
of the fusion protein could be highly immunogenic. The
hGH has also been expressed in sf9 cells [5], eukaryotic
alga [6], and other eukaryotic system. On the whole, the
expression level has been limited. Then the eﬀective Bombyx
mori (B. mori) baculovirus system was employed to express
654bp hGH cDNA encoding signal and mature peptide; as
a result, 160 μg rhGH /mL larvae hemolymph identical to
naturehGHwaspuriﬁed[7].Buttheexpressionlevelwasstill
limited and it was not easy to purify the rhGH expressed by
larvae. Therefore, it was very diﬃcult that the recombinant
hGH could be used as a injectable drug.
Oral administration was a good way for protein drugs.
Zhang et al. proved that protein expressed by silkworm
pupae bioreactor could bring into eﬀect as active cytokine
through oral administration [8]. In this study, we inserted
hGH cDNA encoding mature peptide into BmNPV by
baculovirus system. Constructed recombinant virus infected
diapausing B. mori pupae instead of larvae. Furthermore,
hypophysectomized male rats were used to evaluate the
biological activity of BmrhGH by oral administration.
2.MaterialsandMethods
2.1. Cell Lines and Virus. The B. mori-derived cell line
BmN (conserved by our lab) was maintained at 27
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TC-100 medium (GIBCO) supplemented with 10% fetal
bovine serum. Wild type BmNPV (WT BmNPV, conserved
by our lab) were propagated on BmN cells. The human
erythroleukemia K562 cell was the gift from the Cancer
InstituteofZhejiangUniversity.CellmediumPRMI1640and
fetal bovine serum were purchased from GIBCOL.
2.2. Construction of Recombinant Virus Harboring hGH
Sequence. Construction and identiﬁcation of recombinant
virus vBmrhGH containing hGH were performed as previ-
ously [7]. Brieﬂy, the hGH cDNA was ampliﬁed from the
plasmid PWR-hGH by PCR using the following primers:
forward: 5 GGGGATCCAGTTTCCTACTATACCAC3  and
reverse: 5 TTGAATTCCTAGAAGCCACAGCTGCC3 .E n -
zyme sites of BamHIa n dEcoR I were introduced at
5 -terminus and 3 -terminus, respectively, by designing
primers. PCR products were digested by the two enzymes
and ligated into the same cloning site of pBacPAK8 using T4
DNA ligase. The recombinant transfer vector was designated
as pBacPAK-hGH. The sequence of the inserted hGH DNA
synthesizedbyPCRwasconﬁrmedbynucleotidesequencing.
The puriﬁed DNAs of pBacPAK-hGH and linearized
WT BmNPV were used for cotransfection of BmN cells
(1 × 106 cells) with Lipofectin (Roche Applied Science) as
described previously [9]. Six days after the transfection, the
culturemediumwasremovedandtherecombinantviruswas
isolated by the end point dilution method in 96-well plates.
The recombinant virus isolates, showing cytopathic eﬀect
but no polyhedral inclusion body production, were puriﬁed
by three cycles of plaque assay [10] .T h ep u r i ﬁ e dv i r u sw a s
designated as vBmrhGH. It propagated by infecting a great
amount of BmNcells.The titer of the vBmrhGHpreparation
determined by TCID50 was about 6 ×108 PFU/mL.
Total cellular genomic DNA was isolated from BmN cells
infectedbyvBmrhGHorWTBmNPVandusedforSouthern
blotting to conﬁrm the authenticity of inserted fragment.
They were probed by enzyme-digested hGH cDNA from
PWR-hGHlabeledbyDIG(DIGDNAlabelinganddetection
kit, Roche Applied Science).
2.3. BmrhGH Sample Preparation. B. mori pupae (Qing-
song×Haoyue, purchased from Zhejiang Chinagene
Biomedical Co., Ltd.) were released from cocoons and
inoculated by vBmrhGH or WT BmNPV in body cavity
through a syringe at a multiplicity of 106 PFU/pupa. B.
mori pupae were collected each day and “crashed”. The
pupae mash was centrifuged at 15,000 g for 30 minutes
at 4◦C to remove most of the top lipids and the bottom
depositions. The upper solution was centrifuged for two
more times as described to remove the remaining lipids and
depositions. The fraction of pupae supernatant solution was
stored at −20
◦C as protein sample. Protein samples were
electrophoresed through 15% SDS-PAGE and stained with
Coomassie brilliant blue (CBB).
2.4.WesternBlotting. Thespeciﬁcityoftherecombinantpro-
tein BmrhGH was identiﬁed by Western blotting. Proteins in
polyacrylamide gel were transferred onto PVDF membrane
(Millipore). The blots were blocked with 1% BSA in 20mM
PBS(pH7.4)for1hatroomtemperatureandincubatedwith
1 : 2000dilutionofanti-hGHantiserum(Sigma)inblocking
reagentfor2hoursatroomtemperature.Themembranewas
washedthreetimesinPBShaving0.2%Tween-20(PBST)for
10 minutes and incubated in goat antirabbit IgG antibody
conjugated with horseradish peroxidase (Vector lab, with a
dilution of 1:2000 in blocking reagent) for 1 hour at room
temperature. After washed with PBST for two times and PBS
for another one time, the blots were monitored for color
development in 10mL 100mM Tris-Cl (pH 7.4) including
0.05% diaminobenzidene and 0.2% hydrogen peroxide.
2.5.ELISA. TheamountofrecombinantBmrhGHexpressed
in silkworm pupae was assayed by ELISA according to the
protocolofAusubeletal.[11].TheELISAstandardcurvewas
constructed using a series of hGH standard (from Zhejiang
Shao Yifu Hospital) from 39ng/mL to 1.2μg/mL according
to the manual of Wang and Fan [12]. Protein samples (hGH
standard protein and pupae supernatant solution) were
coated onto 96-well polystyrene plate overnight at 4◦C. The
plate was blocked with 1% BSA in PBS for 2 hours at room
temperature. Then it was incubated with 1:3000 dilution
of anti-hGH antiserum in PBST for 2 hours at 37
◦C. The
platewaswashedandincubatedwith1:2000dilutionofgoat
antirabbit IgG conjugated with peroxidase for 45 minutes at
37
◦C.Wellswerewashedandincubatedwithdetectingbuﬀer
in dark for 20 minutes at room temperature. 2M H2SO4 was
used to stop developing reaction. Values of OD490 were read
inElx800UniversalMicroplateReader(Bio-Tekinstruments,
INC, USA). Standard curve was gained based on the OD490
value and corresponding concentrate of standard protein.
TheamountsofrhGHsynthesizedinpupaeweredetermined
by its OD490 value from the standard curve.
2.6.InVitroAssayforBioactivityofBmrhGH. Thebioactivity
of BmrhGH was identiﬁed by colony-formation analysis
of K562 cells. BmrhGH expressed by silkworm pupa was
diluted with 1M Tris (pH9.0) to a series of concentrations
(40ng/mL, 80ng/mL, 100ng/mL, and 200ng/mL). l.8%
methyl cellulose was added into the 24-well plastic culture
plate for 1mL/well, and then 2 × (PRM1640 + BSA)
medium was also added for 1mL/well. 50μl K562 cell
culture medium (containing approximately 2000 cells) and
50μlB m r h G Hw i t hd i ﬀerent concentrations were mixed,
transferredintothe24-wellplasticcultureplate,andcultured
at the conditions of 37
◦C, 5% CO2. Each sample was
assayed in triplicate. The cells treated with hGH standard
protein weredeﬁnedaspositive control,andthe Tris (pH9.0)
solution-treated cells were deﬁned as negative control. After
cultured for 4 days, the number of colonies was counted
under invert microscope (NIKON, Japan). A cluster of cells
(over 40) was deﬁned as a colony. The colony forming
rate was calculated as follows: colony forming rate = the
number of cell colonies in treatment group/the number of
cell colonies in negative control group × 100%. The colony
forming rate can identify the ability of rhGH for promoting
cell colony-forming.Journal of Biomedicine and Biotechnology 3
2.7. Bioassay for Oral Administration Bioactivity of BmrhGH
on Hypophysectomized Rats. Male Wistar rats, 26∼28d, pro-
videdbyNationalInstitutefortheControlofPharmaceutical
and Biological Products (China), were hypophysectomized
according to Zhu [13]. Beginning two weeks after hypophy-
sectomy, the body weight (BW) of hypox rats was measured
daily for 14 days. The rats whose body weight gain (BWG)
was greater than 1g/day during the 14-day period were
considered incompletely hypox and excluded from the
bioassay. At the end of the 14-day period, the remaining
hypox rats were assigned to treatment groups of eight rats
each according to the BW. Mean BW of hypox rats was 100∼
110g.
Silkworm pupae supernatant solution from insects
infected by vBmrhGH or WT BmNPV was dried frozenly
into powder. When treating animals, protein samples were
prepared by dissolving powders in 0.9% NaCl solution.
Hypox rats were gavaged with protein samples once per
day. One group of Hypox rats was gavaged with the protein
sample of BmrhGH from pupae infected by vBmrhGH. The
dose of treatment was 4.5mg BmrhGH/rat.day. The other
group of animals as control was gavaged with the protein
sample from pupae infected with WT BmNPV at the same
dose. The third group of animals as blank was dealt with
the same volume of 0.9% NaCl solution. The BW of each rat
was measured daily throughout the entire period of bioassay,
beginning on the ﬁrst day of gavage. BWG was used to
analysis.
Rats were killed by cervical dislocation in the morning of
the 14th day. Liver weight of each rat was obtained. Tibias
were anatomized and stored in 10% formaldehyde. After
sliced from the top in an arrowy side, tibias were stained
in 2% AgNO3 for 2 minutes and washed in water. Then
tibias were exposed in strong light until they were brown.
10% Na2S2O3 was used to fasten the color. The stained
tibias were stored in 80% ethanol solution to be observed.
The width of tibias epiphyseal was measured in inverted
microscope (zoomed in 10 × 10). With all statistical analysis
by t-test, diﬀerences were considered statistically signiﬁcant
for P <.05.
3. Results
3.1. Construction of vBmrhGH and Protein Expression in
Silkworm Pupae. A recombinant BmNPV harboring correct
hGH cDNA was generated by recombinant between plasmid
pBacPAK-hGH DNA and WT BmNPV genome lipofected
into BmN cells. By three cycles of plaque assays, the recombi-
nantviruswaspuriﬁed.Southernblottingconﬁrmedthatthe
hGH cDNA was inserted into BmNPV genome successfully.
The B. mori pupae were infected with puriﬁed vBm-
rhGH, and pupae supernatant solution was extracted as
protein sample. The SDS-PAGE analysis of pupae protein
sample showed a speciﬁc 22-kDa band corresponding to the
size of native hGH, which was obviously absent from the
protein samples of both pupae infected by WT BmNPV and
normal pupae (Figure 1(a)). The identity of the protein to
hGH was conﬁrmed by its speciﬁc reaction with anti-hGH
antiserum in a Western blotting (Figure 1(b)).
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Figure 1: SDS-PAGE and Western blotting analysis of BmrhGH
expressed in B. mori pupae. The silkworm pupae were infected
with the recombinant virus vBmrhGH or wild type BmNPV.
The supernatant solution of pupae homogenate was prepared at
120 hours after infection and electrophoresed through 15% SDS-
PAGE (a) and identiﬁed by Western blotting analysis with anti-
hGH antiserum (b). Lanes: M, Low molecular weight marker; 1,
supernatant solution of normal pupae; 2, supernatant solution of
pupae infected by wild type BmNPV; 3, supernatant solution of
pupae infected by recombinant virus vBmrhGH; 4, standard hGH.
Arrow indicates BmrhGH protein.
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Figure 2: Time course of the BmrhGH expression in silkworm
pupae. Pupae were collected each day from 48 hours postinfection
and protein samples were prepared by centrifuging at the speed of
1,5000g. BmrhGH in silkworm pupae extracts was determined by
ELISA. Each value represents the mean of triplicate experiments.
Insilkwormpupae,symptomsofinfectionwereobserved
at 48 hours after inoculation. Pupae began to be soft and
discoloring and dark skin areas began to appear. Almost all
of pupae died at 120 hours. The expression of BmrhGH in B.
mori pupae was quantiﬁed by ELISA (Figure 2). The result
demonstrated that the pupae “bioreactor” could produce
recombinant hGH eﬀectively. At 48 hours after infection, the
amount of BmrhGH was approximately 70μg/ mL pupae
supernatant solution. Then the amount increased day by day
until120hourspostinfection.ThepeaklevelofBmrhGHwas4 Journal of Biomedicine and Biotechnology
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Figure 3: Eﬀects of rhGH on erythroleukemia cell K562 colony
formation.Mostcolonieswerefoundatthedoseof100ng/mLhGH
and BmrhGH, respectively. , standard human growth hormone
protein; , BmrhGH puriﬁed from silkworm pupae.
approximately 890μg/mL supernatant solution and then it
decreased.
3.2. Bioactivity of BmrhGH In Vitro. The bioactivity of
BmrhGHinvitrowasdeterminedbytheeﬀectofitoncolony
formation of human erythroleukemia K562 cells. The result
showed that BmrhGH could stimulate the colony formation
of K562 cells (Figure 3). The ability of K562 cells colony
formation gradually increased along with the increase of
hGH concentration (<100ng/mL). Most cell colonies could
befoundwhentheconcentrationofhGHreached100ng/mL
and then cell colony-forming ability declined when the hGH
concentration continued to increase. The eﬀect of BmrhGH
on the colony formation in K562 cells was similar to hGH
standard protein and the dose-dependent was clear too; the
result was in accordance with the report by Gauwerky [14].
3.3. Biological Activity of BmrhGH on Hypox Rats. The
growth curves of hypox rats’ groups in our laboratory are
presented in Figure 4.V a l u e so fB W G( B W 14-BW1)w e r e
calculated and used for t-test. The BWG of the group treated
with BmrhGH was 12.50 ± 0.831g and that of the control
group was 1.78 ± 0.343g. While in blank group no BWG was
observed. By statistic analysis, it was interesting to note that
there was a signiﬁcant diﬀerence between the group treated
with BmrhGH and the control group (P < .01).
To evaluate the diﬀerence of liver weight and epiphyseal
width between diﬀerent groups, rats were killed at the 14th
day, and the two parameters were measured (Table 1). The
result showed that the mean liver weight of the group treated
with BmrhGH was 4.973 ± 0.1633g. While the mean value
of the control group was 4.424 ±0.0928g.Theresultoft-test
showed that there was a signiﬁcant diﬀerence between them
(P < .05).Comparingtheliverweightbetweentreatedgroup
and blank group, we also found the signiﬁcant diﬀerence
(P < .05).
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Figure 4: Growth curves of hypox rats. Hypox rats were gavaged
with BmrhGH at the dose of 4.5mg/rat.day in silkworm pupae
proteinsample( ).Inthecontrolgroup,hypoxratsweregavaged
with protein sample from silkworm pupae infected by WT BmNPV
at the same dose ( ). The hypox rats of third group were gavaged
with 0.9% NaCl solution as blank ( ).
Table 1: The liver weight and epiphyseal width of hypox rats
gavaged with BmrhGH (mean ± SD).
Group n Liver weight ± SD
(g)
Epiphyseal width ±
SD (μm)
BmrhGH
protein
preparation∗
8 4.973 ± 0.1633 44.777 ± 0.9867
Control 8 4.424 ± 0.0928 39.453 ± 0.9216
Blank 3 4.404 ± 0.0805 40.200 ± 0.9473
∗BmrhGH protein preparation was obtained from pupae infected by
vBmrhGH, and the dosage of BmrhGH was approximately 4.5mg/rat.day.
ControlproteinextractswerefrompupaeinfectedbyWTbaculovirus.Blank
group was treated with 0.9% NaCl solution. “”m e a n sP < .05.
At the same time, the values of epiphyseal width were
compared. We observed that the mean epiphyseal width
of the group treated with BmrhGH was approximately
44.777 ± 0.9867μm, while that of the control group was
39.453 ± 0.9216μm. Result of t-test showed that there was
a similar signiﬁcant diﬀerence between them (P < .05).
4. Discussion
The baculovirus expression system was ﬁrst reported to pro-
ducehumaninterferonαinB.morilarvae[15].Becauseofits
ability to eﬃciently synthesize the highly active products, in
thefollowingdecadesithasbeensuccessfullyusedtoproduce
various recombinant protein. For example, the B. mori
has synthesized hepatitis B virus surface antigen, human
insulin-like growth factor II, human β-interferon, human
interleukin-2, human lactoferrin, and so forth. Therefore,Journal of Biomedicine and Biotechnology 5
BmNcellsandB.moriwere the preferred bioreactors in most
work [16]. In our present work, the diapausing pupae of
silkwormwereusedtoproducerecombinanthGH.Wefound
that this bioreactor was more eﬃcient than other systems.
In our work, the peak expression of BmrhGH was approx-
imately 890μg/mL pupae supernatant solution (Figure 2),
which was corresponded to an average yield of 200∼300μg
per pupa. We also detected that the BmrhGH expressed in
silkworm larvae and the peak production was 200μg/mL
larvae hemolymph (data not shown) and approximately 60∼
70μg per insect, which is similar to previous work [17].
It is interesting to ﬁnd that the expression of BmrhGH
is about 4∼6 times more in diapausing silkworm pupae
than that in larvae. This diﬀerence might be the result of
the diﬀerent protein metabolism of silkworm in diﬀerent
developing stages.
From the present work, we found that the synthesis of
BmrhGH increased at ﬁrst day until reaching a peak, and
then it decreased rapidly. The decrease of BmrhGH might
be the result of a cysteine protease encoded by the BmNPV,
which causes the degradation of the recombinant proteins
and destruction of tissues during the later stages of the
infection. A mutated BmNPV lacking the cysteine proteinase
genewasconstructedtoexpressrecombinantproteinandthe
stability of recombinant protein could be enhanced in later
postinfection stage [18].
The physiological role of hGH is achieved by stimulating
the synthesis of SM factor in liver. At the same time,
many reports have proven that hGH itself can also act
directly on multiple tissues and organs, promoting synthetic
metabolism and growth [19]. The results of tests in vitro
showed that ng-level hGH can promote the physiological
activity of many cells, including thymus cells [20], rat epithe-
lial cells [21], and islet cells [22]. Gauwerky et al. showed
that hGH can promote the colony formation of human
erythroleukemia K562 cells [14]. In present study, eﬀects
of BmrhGH on colony formation of K562 cells at diﬀerent
dose were investigated. The most colonies were found at
the dose of 100ng/mL hGH and BmrhGH, respectively. The
resultindicatedthatrhGHexpressedbyB.moripupashowed
bioactivity similar to hGH. Additionally, FBS is composed
of many complex compositions which might contain some
hormone-like factors and could aﬀect the colony formation
of K562 cells. Therefore, the FBS was replaced by BSA in the
cell culture medium, and thus the eﬀect on colony formation
of K562 was only caused by BmrhGH.
Biological activities of hGH preparations have been
determined mostly by the body weight gain (BWG) assay
[23],orthetibiaassaytest[8]bythewayofinjection,bothin
hypoxrats.Hypoxratswerealsousedinourstudytoevaluate
the biological activity of expressed BmrhGH. For thousands
of years, pupa was nutritious food, and we tried the way of
oral administration instead of injection. We are interested
to ﬁnd that the rat’s body weight increased signiﬁcantly
(Figure 4, P < .01), and we also discovered the improving
activity of BmrhGH in pupae extractsto both the parameters
of tibia epiphysial growth plate width and liver weight. It
could be concluded that the BmrhGH in pupae extracts had
biological activity by oral administration in hypox rats. We
deduced that there were some factors in pupae that could
protect functional proteins from digesting in stomach, or
BmrhGH was digested into functional peptides that could
be absorbed by body. More work is needed to illustrate
it. The previous studies in our lab proved that BmrhGM-
CSF, a 29 kDa recombinant hGM-CSF protein expressed by
silkworm pupae bioreactor, could bring into eﬀect as active
cytokine through oral administration [24]. The clinical trial
for BmrhGM-CSF has been carried out and demonstrated
that the oral administered BmrhGM-CSF was absorbed into
the blood [25]. We also expressed many useful proteins by
silkworm pupae bioreactor, such as cholera toxin B subunit–
insulin fusion protein, Osteoprotegerin, Human lactoferrin,
and so forth, and also found the bioactivities of them by oral
administration [16, 26–28]. Due to the oral administration
activity, BmrhGH might be a potential choice for short
stature dementia or Alzheimer’s disease.
More over, another interesting result in our work is that
there are some other proteins in silkworm pupae that are
reactive to anti-hGH antiserum (Figure 1(b)). Interestingly,
thebandwasalsofoundintheproteinsamplefromsilkworm
pupae infected by WT BmNPV. BWG bioassay of hypox rats
indicated that the protein sample from WT virus infected
pupae is eﬀective compared with the blank group (P < .05).
The result indicated that there might be some proteins in B.
mori pupae with similar characteristic and activity to hGH.
More studies on this deduction are doing in our laboratory.
5. Conclusions
Taken together, the recombinant hGH protein BmrhGH
was synthesized with a level of approximately 890μg/mL
pupae supernatant solution, which was ﬁve times more than
the level using larvae. The animal experiments proved that
BmrhGH has a high oral administration bioactivity. Due to
the high activity and oral administration, BmrhGH might
be used as a potential drug for short stature dementia or
Alzheimer’s disease and would be a low-cost choice.
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